Stem cell guidelines open door to more permissive research on human embryos
By Kelly Servick,
Science
| 05. 26. 2021
The world’s largest stem cell society this week signaled a willingness to reconsider a long-standing restriction on laboratory efforts to grow and study human embryos. In new guidelines, the International Society for Stem Cell Research (ISSCR) also spotlights a possible alternative to using embryos that might be less ethically fraught: emerging methods to model stages of human development with stem cells. ISSCR’s influential guidelines previously put the culture of human embryos beyond 14 days postfertilization in its most restrictive category three: “prohibited research activities.” The new guidelines, drafted by a task force of scientists and ethicists, omit longer embryo culture from this category and encourage a public discussion about allowing it.
The guidelines aren’t legally enforceable. Laws limiting embryo research to either 14 days or formation of a structure called the primitive streak exist in several countries, including the United Kingdom, Sweden, and South Korea. But ISSCR “has an important soft power,” says Annelien Bredenoord, a bioethicist at the University Medical Center Utrecht who is a member of ISSCR’s ethics committee but not part of the guideline task force...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...